1024P Initial Clinical Results of BT-001, an Oncolytic Virus Expressing an Anti-Ctla4 Mab, Administered As Single Agent and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors

S. Champiat, C. Lebbe,J-F. Baurain,A. Italiano,M. Sakkal, C. Spring-Giusti,N. Stojkowitz, M. Brandely, A. Sadoun, A. Ropenga, M. Semmrich, A. McAllister,M. Chisamore, P. Cassier

Annals of Oncology（2024）

Cited 0|Views4

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined